WorldCare Clinical announced new rapid turnaround services for imaging safety reviews. The new service offering is designed to deliver safety assessments within 24 hours of receiving scans.
WCC is providing new rapid safety assessment services in response to the growing emphasis that regulatory agencies are placing on safety reviews. Through its affiliation with Proscan Reading Services (PRS), a provider of large-volume teleradiology services accredited by the American College of Radiology, WCC is offering an integrated reading service that provides comprehensive safety assessments within 24 hours of receiving scans, seven days a week and can deliver emergency reads even faster, if required. Using an in-house team of practicing, board-certified, sub specialty-trained radiologists, WCC assembles reading teams that have extensive experience relevant to the disease population being studied.
“Efficacy assessments in imaging studies are often facilitated by a batch review, which can result in extended delays in determining incidental safety findings,” said Richard Walovitch, PhD, president of WorldCare Clinical, LLC. “We understand the time-critical nature of these assessments and have developed this integrated reading service to address the need for prompt and accurate safety assessments.”
Using WCC’s proven WorldPRO image management platform, a comprehensive system that collects, anonymizes, integrates, and presents imaging data to multiple reviewers in a regulatory-compliant, efficient and effective manner, the new rapid turnaround safety assessment service includes the following key functions:
· An asynchronous upload ability that allows sites to queue up multiple images for electronic submission; files are transferred automatically for aquick turnaround, decreasing the time and cost of sending data by courier.
· Integration with a web-based viewer enabling radiologists to complete safety reviews anytime, anywhere.
· Automatic notifications sent immediately to the site upon completion of the safety review.
For more information about WCC’s full range of services, including its imaging safety review services, visit: http://www.wcclinical.com/what-we-do/#page-Special-Services.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.